Joltoo
Grants
Browse catalogTailored listsFind your matchesFundersPrograms
InvestorsAdvisoryInsights
DeepTech 2026 PlaybookRequest access
Browse all
  1. Home
  2. /Investors
  3. /Biotech
  4. /Dynamk Capital
DC

Dynamk Capital

Pure DeepTechNew York, United StatesActiveWebsiteLinkedIn
Stage FocusSeed, Series A, Series B+
GeographyUS, Canada
TypeVC
Last Activity2026
Industry Focus
Industries
BiotechMedtechHardware
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio

Dynamk Capital is a New York venture capital firm founded in 2017, investing in life science industrials — the tools, technologies, and services used to discover, develop, and manufacture cell and gene therapies.

Its dozen-plus portfolio spans cell therapy manufacturing and analytics, including RoosterBio (cell therapy raw materials, with recent partnerships spanning Nikon, ZEISS, and Secretome T...

Notable Investments
R
RoosterBio
b
bit.bio
A
Alpenglow Biosciences
X
Xcell Biosciences
E
Envisagenics
C
Curi Bio
V
Vernal Biosciences
V
Vectron Biosolutions
V
Virica Biotech
L
Lucid Scientific
c
cellFE
B
Bionter

Similar Funds

LV

Lumira Ventures

Toronto, Canada

Pure DeepTechBiotechMedtechRoboticsSeedSeries A
3B

3E Bioventures Capital

China

Pure DeepTechBiotechMedtechSeedSeries A
AL

Advent Life Sciences

London, United Kingdom

Pure DeepTechBiotechMedtechSeedSeries A
AV

Alix Ventures

San Francisco, United States

Pure DeepTechBiotechSynthetic BiologyMedtechPre-SeedSeed
Bold Capital Partners

Bold Capital Partners

Santa Monica, United States

Pure DeepTechBiotechAIMedtechSeedSeries A
BC

Boundary Capital

Northampton, United Kingdom

Pure DeepTechBiotechMedtechAdvanced MaterialsSeedSeries A
Work at Dynamk Capital? Claim this page
Joltoo
PricingInsightsTailored lists
Privacy PolicyTerms of Service
Security
© 2026 Joltoo. All rights reserved.